Altering bioavailability in curcumin derivatives- an in silico study

dc.contributor.authorLakna, W. P. D
dc.contributor.authorMohomed, A
dc.contributor.authorKeerthi ,A. P. P
dc.date.accessioned2025-09-17T06:08:49Z
dc.date.available2025-09-17T06:08:49Z
dc.date.issued2025-05
dc.descriptionPage 58 Abstract No: 2025_311
dc.description.abstractCurcumin and its derivatives exhibit diverse pharmacological activities, including antioxidant, anti-inflammatory, anti-proliferative, antibacterial, analgesic, and antiviral effects. However, their therapeutic potential is often limited by poor bioavailability, primarily due to low intestinal absorption. In this in silico study, we screened 198 curcumin derivatives identified in previous studies for toxicological profiles, bioavailability, and drug-likeness.
dc.identifier.urihttps://dr.ichemc.ac.lk/handle/123456789/441
dc.language.isoen
dc.publisherInstitute of Chemistry Ceylon
dc.relation.ispartofseries42; 2
dc.subjectCurcumin derivatives
dc.subjectdrug-likeness
dc.subjectintestinal absorption
dc.subjectPepT1
dc.subjectmolecular docking
dc.titleAltering bioavailability in curcumin derivatives- an in silico study
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Altering bioavailability in curcumin derivatives- an in silico study7b640175-7f73-467b-8bab-7d93cb797d35.pdf
Size:
448.41 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections